ERGOT Faculty, Macey Henderson, JD PhD, was elected to a 3-year term on the Organ Procurement and Transplantation Network (OPTN) Board of Directors. Henderson will serve as a Patient and Donors Affairs Representative. The Board of Directors is the governing body that oversees and participates in developing policies for operating the OPTN that provide equitable organ allocation to patients registered on the national waiting list, ensure quality standards for membership, and establish data submission requirements. Currently, the same board that serves the OPTN also serves the United Network for Organ Sharing (UNOS), the organization that holds the contract to operate the OPTN.
Completing the trilogy of papers published in the December issue of the American Journal of Transplantation that was dedicated to living donors, our lab looks for Patterns of End-Stage Renal Disease Caused by Diabetes, Hypertension, and Glomerulonephritis in Live Kidney Donors.
We looked at studies averaging less than 10 years of follow-up to better understand postdonation ESRD.
Following the American Journal of Transplantation’s theme of giving for their December article, they published our paper featuring our Smartphone App for Increasing Live Organ Donation.
The idea came from talking to waitlisted candidates for kidney transplant who reported substantial barriers to identifying a live donor. Our app aims to help ESRD patients eligible for transplantation create a dialog that tells their story and helps them reach out to friends and family through social medias.
That app, as of this blog post, is still in development.